FOLH1 and prostate cancer: In a large, multicentre study evaluating 600 patients with newly diagnosed with intermediate and high-risk prostate cancer, we showed that PSMA PET/CT may have a valuable role in local tumour staging when pathological tumour stage in the radical prostatectomy specimen was used as the reference standard.